DK0584715T3 - Fremgangsmåde til isolering og dyrkning af transformerede celler og anvendelse af disse til fremstilling af antistoffer ret - Google Patents

Fremgangsmåde til isolering og dyrkning af transformerede celler og anvendelse af disse til fremstilling af antistoffer ret

Info

Publication number
DK0584715T3
DK0584715T3 DK93113227T DK93113227T DK0584715T3 DK 0584715 T3 DK0584715 T3 DK 0584715T3 DK 93113227 T DK93113227 T DK 93113227T DK 93113227 T DK93113227 T DK 93113227T DK 0584715 T3 DK0584715 T3 DK 0584715T3
Authority
DK
Denmark
Prior art keywords
transformed cells
isolating
produce antibodies
culturing transformed
individual
Prior art date
Application number
DK93113227T
Other languages
English (en)
Inventor
Ulrich Dr Kuebler
Rainer Hoffmann
Original Assignee
Kuebler Gmbh Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6466484&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0584715(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kuebler Gmbh Dr filed Critical Kuebler Gmbh Dr
Application granted granted Critical
Publication of DK0584715T3 publication Critical patent/DK0584715T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3038—Kidney, bladder
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C12N5/0694—Cells of blood, e.g. leukemia cells, myeloma cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
DK93113227T 1992-08-26 1993-08-18 Fremgangsmåde til isolering og dyrkning af transformerede celler og anvendelse af disse til fremstilling af antistoffer ret DK0584715T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4228389A DE4228389C2 (de) 1992-08-26 1992-08-26 Gewinnung und Kultivierung transformierter Zellen

Publications (1)

Publication Number Publication Date
DK0584715T3 true DK0584715T3 (da) 1999-08-23

Family

ID=6466484

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93113227T DK0584715T3 (da) 1992-08-26 1993-08-18 Fremgangsmåde til isolering og dyrkning af transformerede celler og anvendelse af disse til fremstilling af antistoffer ret

Country Status (8)

Country Link
US (1) US5529903A (da)
EP (1) EP0584715B1 (da)
JP (1) JP3502125B2 (da)
AT (1) ATE174959T1 (da)
DE (4) DE4244715C2 (da)
DK (1) DK0584715T3 (da)
ES (1) ES2126618T3 (da)
GR (1) GR3029774T3 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7659119B2 (en) 1996-02-12 2010-02-09 Argos Therapeutics, Inc. Method and compositions for obtaining mature dendritic cells
CA2251186A1 (en) * 1996-04-05 1997-10-16 The Johns Hopkins University A method of enriching rare cells
DE29708743U1 (de) * 1997-05-16 1998-09-17 Kuebler Gmbh Dr Apheresevorrichtung
US7396681B1 (en) 1998-03-27 2008-07-08 Gabriele Multhoff Application of Hsp70 proteins
DE19833738A1 (de) * 1998-07-27 2000-02-03 Michael Giesing Verfahren zur Isolierung von Krebszellen aus zellhaltigen Körperflüssigkeiten sowie Sets zur Durchführung dieses Verfahrens
JP2002529704A (ja) * 1998-10-29 2002-09-10 セル ワークス インコーポレイテッド 単一細胞の複数マーカー特徴付け
GB9827430D0 (en) * 1998-12-11 1999-02-03 Ludwig Inst Cancer Res Differential expression in primary breast cancer
AU2412800A (en) * 1999-01-15 2000-08-01 Light Sciences Corporation Noninvasive vascular therapy
EP2359689B1 (en) 2002-09-27 2015-08-26 The General Hospital Corporation Microfluidic device for cell separation and use thereof
DE10317389A1 (de) 2003-04-15 2004-11-04 Dr. Kübler GmbH Synergistisch wirkende Kombination von Phenylbutyrat und Aminobenzoesäure zur Krebstherapie
DE10355702A1 (de) * 2003-06-12 2005-01-13 Kübler, Ulrich, Dr. Methode zur Diagnose und Therapie von Gliomen und Astrozytomen in einem sehr frühen Stadium
DE10342322B4 (de) * 2003-09-12 2006-06-22 Kübler, Ulrich, Dr. Verfahren zur Herstellung von endothelialen Progenitorzellen aus apheretisch gewonnenen Monozyten menschlichen oder tierischen Blutes
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
WO2007106545A2 (en) * 2006-03-13 2007-09-20 Veridex, Llc Propagation of primary cells
EP2029779A4 (en) 2006-06-14 2010-01-20 Living Microsystems Inc HIGHLY PARALLEL SNP GENOTYPING UTILIZATION FOR FETAL DIAGNOSIS
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
EP2589668A1 (en) 2006-06-14 2013-05-08 Verinata Health, Inc Rare cell analysis using sample splitting and DNA tags
WO2008111990A1 (en) * 2006-06-14 2008-09-18 Cellpoint Diagnostics, Inc. Rare cell analysis using sample splitting and dna tags
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
PL2562268T3 (pl) 2008-09-20 2017-06-30 The Board Of Trustees Of The Leland Stanford Junior University Nieinwazyjna diagnostyka aneuploidii płodu za pomocą sekwencjonowania
US20120170966A1 (en) * 2011-01-03 2012-07-05 Novak Jr James Russell Writing implement with storage enclosure
WO2019204391A1 (en) * 2018-04-19 2019-10-24 Robert Caruso Cryo-inactivated cancer cells for cancer immunotherapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2925789A (en) * 1987-12-17 1989-07-19 Browning's Clinical Pathology Services Limited Lymphokine activation of cells for adoptive immunotherapy, e.g. of hiv infection
WO1989007445A1 (en) * 1988-02-11 1989-08-24 Board Of Regents, The University Of Texas System Improved method for treatment of cancer with activated oncolytic leukocytes
US5112298A (en) * 1990-06-25 1992-05-12 Baxter International Inc. Apheresis method and device

Also Published As

Publication number Publication date
GR3029774T3 (en) 1999-06-30
ES2126618T3 (es) 1999-04-01
EP0584715B1 (de) 1998-12-23
EP0584715A2 (de) 1994-03-02
DE59309239D1 (de) 1999-02-04
EP0584715A3 (de) 1995-02-22
DE9321535U1 (de) 1999-08-05
ATE174959T1 (de) 1999-01-15
DE4244715A1 (de) 1994-04-28
DE4228389C2 (de) 1994-07-21
US5529903A (en) 1996-06-25
JP3502125B2 (ja) 2004-03-02
DE4244715C2 (de) 1995-06-14
JPH06205671A (ja) 1994-07-26
DE4228389A1 (de) 1994-03-03

Similar Documents

Publication Publication Date Title
DK0584715T3 (da) Fremgangsmåde til isolering og dyrkning af transformerede celler og anvendelse af disse til fremstilling af antistoffer ret
ES2124209T3 (es) Anticuerpos monoclonales mejorados reactivos con caquectina.
ATE504601T1 (de) Anti-cd3-antikörper zur verwendung zur induzierung von immunsuppression
MY108526A (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
DE69032979D1 (de) Bispezifische heteroantikörper mit zweifachen effektorfunktionen
DK101888D0 (da) Immunmodulerende midler og anvendelse af disse
DE3687884T2 (de) Monoklonale antikoerper und verfahren zum nachweis von pilzpathogenen.
DE69127487D1 (de) Verfahren zum Nachweis der Alzheimer-Krankheit
ATE161581T1 (de) Monoklonale antikörper gegen humane pankreas- inselzellen
DK0610335T3 (da) Fremgangsmåder til udformning af rekombitope peptider
ATE171473T1 (de) Humanisierte monoklonale antikörper gegen humanes interleukin - 4
ATE206621T1 (de) Il-8 antagonisten zur behandlung von asthma
EP0396505A3 (en) Monoclonal antibodies specific for an immunoglobulin isotype
SE9201281D0 (sv) New human monoclonal antibodies, and a method for preparation thereof
NO883603L (no) Humane monoklonale antistoffer og profylaktiske og terapeutiske midler mot infektioese sykdommer inneholdende disse som effektiv bestanddel.
DE3850750T2 (de) Verfahren zur Verhütung von GVHD.
DK276185D0 (da) Monoklonale antistoffer,fremgangsmaade til fremstilling af disse samt deres diagnostiske anvendelse
DK288389D0 (da) Fremgangsmaade til paavisning af marek-virus hos fjerkrae og saet til udfoerelse af fremgangsmaaden
DK0476059T3 (da) Fremgangsmåder til forøgelse af modificeringshastigheden for metastabile bindinger
DK373389D0 (da) Fremgangsmaade til selektion af anti-idiotype antistoffer og anvendelse af disse til diagnostiske og terapeutiske formaal
ES2059726T3 (es) Anticuerpos monoclonales que reconocen el itsp humano, hibridomas que producen los mismos, y su preparacion y uso.
IT8821547A0 (it) Metodo immunologico per la determinazione di anticorpi anti antigeni di microorganismi, mediante anticorpi antiidiotipo e mezzi adatti allo scopo.
SU1692146A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus l. - продуцент моноклональных антител к 146 s-компоненту вируса ящура o
DK616989D0 (da) Humane monoklonale antistoffer, der specifikt genkender rabiesvirusceller, celler, der prducerer denne virus, formuleringer, der indeholder virusen, samt fremstilling af disse antistoffer